After adjusting for age, sex, obesity and indication for statins, pre-admission statin use was associated with a decreased risk of death [adjusted OR: 0.64 (95% CI: 0.25–1.65)] and level 2/3 admission [adjusted OR: 0.66 (95% CI: 0.33–1.29)] but again, these results did not reach statistical significance.
← all excerpts
Pre-admission statin use and in-hospital severity of 2009 pandemic influenza A(H1N1) disease.
2
—
—
The sentences
Even after adjustment for age, sex, obesity and indication for statin, the association between pre-admission statin use and severe outcome failed to reach statistical significance although the point estimates are compatible with a clinically significant protective effect [adjusted OR: 0.72 (95% CI: 0.38–1.33)].